ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Leo Cancer Care closed a $65 million Series D funding round. The company develops patient-positioning technology for radiation therapy. The funding will support expansion of its upright radiation therapy systems.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
FORE Biotherapeutics Raises $67.4M Series D-2